Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ad-Free, Unlimited access)​
NO CREDIT CARD REQUIRED
BIMI
Upturn stock ratingUpturn stock rating

Bimi International Medical Inc (BIMI)

Upturn stock ratingUpturn stock rating
$0.03
Last Close (24-hour delay)
upturn advisory
PASS
  • BUY Advisory
  • SELL Advisory (Profit)​
  • SELL Advisory (Loss)​
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

06/16/2025: BIMI (1-star) is currently NOT-A-BUY. Pass it for now.

Upturn Star Rating

rating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

Number of Analysts

rating

Analysts rated it

Very few follow this stock; limited insights, higher-risk early investing.

1 Year Target Price $0

1 Year Target Price $0

Analysts Price Target For last 52 week
$0Target price
Low$
Current$0.03
high$

Analysis of Past Performance

Type Stock
Historic Profit -43.67%
Avg. Invested days 35
Today’s Advisory PASS
Upturn Star Rating Upturn stock ratingUpturn stock rating
Upturn Advisory Performance Upturn Advisory Performance 4.0
Stock Returns Performance Upturn Returns Performance 1.0
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 06/16/2025

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 0.49M USD
Price to earnings Ratio -
1Y Target Price 12.5
Price to earnings Ratio -
1Y Target Price 12.5
Volume (30-day avg) -
Beta -0.54
52 Weeks Range 0.00 - 1.65
Updated Date 06/29/2025
52 Weeks Range 0.00 - 1.65
Updated Date 06/29/2025
Dividends yield (FY) -
Basic EPS (TTM) -6.39

Earnings Date

Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin -83.2%
Operating Margin (TTM) -124.83%

Management Effectiveness

Return on Assets (TTM) -13.01%
Return on Equity (TTM) -103.78%

Valuation

Trailing PE -
Forward PE -
Enterprise Value 3477339
Price to Sales(TTM) 0.04
Enterprise Value 3477339
Price to Sales(TTM) 0.04
Enterprise Value to Revenue 0.28
Enterprise Value to EBITDA -2.66
Shares Outstanding 13960700
Shares Floating 1484160
Shares Outstanding 13960700
Shares Floating 1484160
Percent Insiders 93.51
Percent Institutions -

Analyst Ratings

Rating -
Target Price -
Buy -
Strong Buy -
Buy -
Strong Buy -
Hold -
Sell -
Strong Sell -
Strong Sell -

ai summary icon Upturn AI SWOT

Bimi International Medical Inc

stock logo

Company Overview

overview logo History and Background

Bimi International Medical Inc., formerly known as Bimi Inc, focuses on providing healthcare products and services. It has evolved through strategic acquisitions and partnerships, mainly operating in China's healthcare market. Specific founding year details are unavailable.

business area logo Core Business Areas

  • Healthcare Products Distribution: Distribution of medical devices, equipment, and healthcare-related products.
  • Healthcare Services: Provision of medical consultation, diagnostics, and related healthcare services through its network.

leadership logo Leadership and Structure

Leadership details, including the CEO and key executives, and the specific organizational structure are not readily and reliably available. General information suggest a structure with management teams overseeing various business segments.

Top Products and Market Share

overview logo Key Offerings

  • Medical Devices: Distribution of various medical devices. Market share and revenue contribution are not publicly available. Competitors include larger multinational medical device distributors and manufacturers in China, such as Medtronic (MDT) and Siemens Healthineers (not directly traded on US stock exchanges).
  • Healthcare Products: Provision of a range of healthcare products. Market share and revenue contribution are not publicly available. Competitors are other local distributors and online retailers.

Market Dynamics

industry overview logo Industry Overview

The healthcare industry in China is experiencing significant growth driven by an aging population, increasing healthcare awareness, and government initiatives to improve healthcare access. It is also impacted by regulatory changes and shifts towards domestic production.

Positioning

Bimi International Medical Inc. aims to position itself as a key player in the Chinese healthcare market through distribution and service offerings. Competitive advantages are unclear due to limited public information. The size is considered as a disadvantage compared to larger international companies.

Total Addressable Market (TAM)

The TAM for healthcare products and services in China is substantial and growing rapidly, estimated to be in the hundreds of billions of dollars. Bimi's positioning relative to the TAM is difficult to assess without specific market share data.

Upturn SWOT Analysis

Strengths

  • Established distribution network (potentially within specific regions)
  • Focus on the Chinese healthcare market
  • Potential for growth in a growing market

Weaknesses

  • Limited financial resources compared to larger competitors
  • Lack of significant brand recognition
  • High dependence on the Chinese market
  • Limited available information about the company's current operations and financial state.

Opportunities

  • Expansion into new geographic areas within China
  • Acquisition of smaller healthcare businesses
  • Partnerships with larger international healthcare companies
  • Increased demand for healthcare products and services in China

Threats

  • Increased competition from larger domestic and international players
  • Changing government regulations and policies
  • Economic slowdown in China
  • Fluctuations in currency exchange rates

Competitors and Market Share

competitor logo Key Competitors

  • MDT
  • BSX
  • JNJ

Competitive Landscape

Bimi International Medical Inc faces significant challenges in competing with larger, more established players in the healthcare market. Its lack of scale and brand recognition are major disadvantages.

Growth Trajectory and Initiatives

Historical Growth: Insufficient data to evaluate historical growth trends.

Future Projections: No reliable projections are available due to limited information.

Recent Initiatives: Recent strategic initiatives are not readily available.

Summary

Bimi International Medical Inc. operates in China's growing healthcare market. However, it faces significant competition from larger, more established companies. The availability of financial information is limited, making it difficult to assess the company's financial health and growth potential. Bimi needs to improve its brand recognition and build strategic partnerships to succeed in the long term.

Peer Comparison

Sources and Disclaimers

Data Sources:

  • SEC Filings (limited availability)
  • Company Website
  • Industry Reports

Disclaimers:

The information provided is based on publicly available sources and may not be complete or accurate. This analysis is for informational purposes only and should not be considered investment advice. There is limited financial information available for this company.

Upturn AI SummarizationUpturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI SummarizationUpturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI SummarizationUpturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI SummarizationUpturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.

About Bimi International Medical Inc

Exchange NASDAQ
Headquaters New York, NY, United States
IPO Launch date 2006-10-18
CEO & Director Mr. Tiewei Song
Sector Healthcare
Industry Pharmaceutical Retailers
Full time employees 296
Full time employees 296

BIMI Holdings Inc., together with its subsidiaries, engages in the retail and wholesale distribution of medical devices, and pharmaceutical and other healthcare products in the People's Republic of China. The company operates in four segments: Wholesale Pharmaceuticals, Wholesale Medical Devices, Medical Services, and Retail Pharmacies. It distributes Stryker spinal products, Olympus endoscopes, imported imaging products, and diagnostic imaging equipment to drug stores, private clinics, pharmaceutical dealers, and hospitals in the Southwest region of the People's Republic of China. The company also distributes varieties of products, including raw ingredients for pharmaceutical products, antibiotics, cardiovascular drugs, and anti-obesity medicines. In addition, it offers prescription and over-the-counter drugs, nutritional supplements, traditional Chinese medicines, personal and family care products, medical devices, and miscellaneous items under the Lijiantang Pharmacy brand name. Further, the company provides medical services in the hospitals, as well as IT research and development services; and operates two private hospitals in China. It sells its medicine and other healthcare products to customers through its directly owned stores. The company was formerly known as BIMI International Medical Inc. and changed its name to BIMI Holdings Inc. in January 2024. BIMI Holdings Inc. was incorporated in 2000 and is headquartered in New York, New York.